Cargando…
An Isoform of the Oncogenic Splice Variant AIMP2-DX2 Detected by a Novel Monoclonal Antibody
AIMP2-DX2, an exon 2-deleted splice variant of AIMP2 (aminoacyl-tRNA synthetase-interacting multifunctional protein 2), is highly expressed in lung cancer and involved in tumor progression in vivo. Oncogenic function of AIMP2-DX2 and its correlation with poor prognosis of cancer patients have been w...
Autores principales: | Kim, Dae Gyu, Nguyen, Thi Thu Ha, Kwon, Nam Hoon, Sung, Junsik, Lim, Semi, Kang, Eun-Joo, Lee, Jihye, Seo, Woo Young, Kim, Arum, Chang, Yoon Soo, Shim, Hyunbo, Kim, Sunghoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356629/ https://www.ncbi.nlm.nih.gov/pubmed/32471182 http://dx.doi.org/10.3390/biom10060820 |
Ejemplares similares
-
Anticancer Activity of Pyrimethamine via Ubiquitin Mediated Degradation of AIMP2-DX2
por: Kim, Dae Gyu, et al.
Publicado: (2020) -
AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis
por: Kim, Dae Gyu, et al.
Publicado: (2022) -
Ratio of Autoantibodies of Tumor Suppressor AIMP2 and Its Oncogenic Variant Is Associated with Clinical Outcome in Lung Cancer
por: Jung, Ji Ye, et al.
Publicado: (2017) -
Data on optimization of expression and purification of AIMP2-DX2 protein in Escherichia coli
por: Jha, Roshan, et al.
Publicado: (2017) -
Synthesis and discovery of the first potent proteolysis targeting chimaera (PROTAC) degrader of AIMP2-DX2 as a lung cancer drug
por: Lee, BoRa, et al.
Publicado: (2022)